Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate

US9492337B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9492337-B2
Application numberUS-201313868225-A
CountryUS
Kind codeB2
Filing dateApr 23, 2013
Priority dateApr 24, 2012
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a substrate that includes one or more human milk oligosaccharides. A disposable absorbent article may include the substrate having one or more human milk oligosaccharides.

First claim

Opening claim text (preview).

What is claimed is: 1. A substrate selected from the group consisting of a nonwoven web, a film, a tissue, a pulp, and a superabsorbent polymer, wherein at least a portion of the substrate has added thereto a formulation comprising one or more human milk oligosaccharides, the one or more human milk oligosaccharides comprising a linear or branched chain of carbohydrate units wherein the overall carbohydrate unit number is from 2 to no more than 32, each carbohydrate unit containing 3 to 6 carbon atoms, wherein said carbohydrate units are covalently bound to each other directly or indirectly by an ether function, the substrate and the formulation being adapted to effect transfer of the formulation to a baby's skin. 2. The substrate of claim 1 , wherein one or more human milk oligosaccharides are selected from the group consisting of: lactose, 2′-fucosyllactose, 3′-fucosyllactose, difucosyllactose, lacto-N-tetraose (type 1), lacto-N-neo-tetraose (type 2), lacto-N-fucopentaoses I, II, III, IV and V, lacto-N-fucohexaose I, lacto-N-hexaose, lacto-N-neohexaose, fucosyllacto-N-hexaose I and IV, fucosyllacto-N-neohexaose, lacto-N- difuco-hexaoses I and II, lacto-N-octaoses, sialyα2-3lactose, sialyα2-6lactose, sialyl-N-tetraose a, b and c, and disialyl-lacto-N-tetraose, and mixtures thereof. 3. The substrate of claims 1 , wherein the one or more human milk oligosaccharides are selected from the group consisting of: fucose-α(1→2)galalactose_βas a disaccharide unit, 2′-fucosyllactose, 3′-fucosyllactose, lacto-N-difuco-tetraose, lacto-N-difuco-hexose I, lacto-N-difuco-hexose II, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, and lacto-N-fucopentaose V, and mixtures thereof. 4. The substrate of claims 1 , wherein the substrate is selected from the group consisting of a nonwoven web, a film, and a tissue wherein one or more human milk oligosaccharides which are either selected from the group consisting of: lactose, 2′-fucosyllactose, 3′-fucosyllactose, difucosyllactose, lacto-N-tetraose (type 1), lacto-N-neo-tetraose (type 2), lacto-N-fucopentaoses I, II, III, IV and V, lacto-N-fucohexaose I, lacto-N-hexaose, lacto-N-neohexaose, fucosyllacto-N-hexaose I and IV, fucosyllacto-N-neohexaose, lacto-N-difuco-hexaoses I and II, lacto-N-octaoses, sialyα2-3lactose, sialyα2-6lactose, sialyl-lacto-N-tetraose a, b and c, and disialyl-lacto-N-tetraose, and mixtures thereof, or selected from the group consisting of: fucose-α(1→2)galalactose_βas a disaccharide unit, 2′-fucosyllactose, 3′-fucosyllactose, lacto-N-difuco-tetraose, lacto-N-difuco-hexose I, lacto-N-difuco-hexose II, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, and lacto-N-fucopentaose V, and mixtures thereof; represent at least about 50% of the total weight of all the human milk oligosaccharides comprised by the substrate. 5. The substrate of claim 1 , wherein the human milk oligosaccharides are comprised in a formulation, wherein formulations include emulsions, creams, ointments, salves, powders, suspensions, solutions, encapsulations, gels and combinations thereof. 6. The substrate of claim 5 , wherein the formulation includes an immobilizing agent. 7. The substrate of claim 1 , wherein the substrate is selected from the group consisting of a nonwoven web, a film, and a tissue and wherein at least a portion of the substrate is coated or impregnated with one or more human milk oligosaccharides with an amount of about 0.2 g to about 200 g of all human milk oligosaccharides per square meter. 8. A wipe wherein one or more substrates according to claim 1 form at least a portion of the wipe. 9. A disposable absorbent article comprising the substrate of claim 1 , wherein the disposable absorbent article is selected from the group consisting of a diaper, a pant, an adult incontinence product, an absorbent insert for a diaper or pant, and a feminine hygiene product, wherein the disposable absorbent article comprises a backsheet, a topsheet, and an absorbent core disposed between the backsheet and the topsheet. 10. The disposable absorbent article of claim 9 , wherein the substrate forms at least a portion of the topsheet or a portion of a layer directly underneath the topsheet. 11. The disposable absorbent article of the claim 5 , wherein the formulation is coated or sprayed onto the topsheet. 12. The disposable absorbent article of claim 9 further comprising barrier leg cuffs, wherein the barrier leg cuffs comprise the substrate. 13. The disposable absorbent article of claim 9 further comprising an acquisition system, wherein the absorbent core or the acquisition system comprises the substrate. 14. The disposable absorbent article of claims 8 , wherein the overall amount of all human milk oligosaccharides per disposable absorbent article is between about 0.02 g and about 0.5 g. 15. A process for manufacturing a disposable absorbent article comprising the substrate of claim 1 , the process comprising the step of applying an amount of one or more human milk oligosaccharides to the substrate. 16. The process of claim 15 , wherein the human milk oligosaccharides are applied to the substrate via spraying, printing, coating, slot coating, extrusion, microencapsulation and any combination thereof.

Assignees

Inventors

Classifications

  • Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria · CPC title

  • Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides · CPC title

  • Liquid-swellable gel-forming materials, e.g. super-absorbents · CPC title

  • Additives, e.g. for odour, disinfectant or pH control · CPC title

  • Apparatus or processes for manufacturing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9492337B2 cover?
The present disclosure relates to a substrate that includes one or more human milk oligosaccharides. A disposable absorbent article may include the substrate having one or more human milk oligosaccharides.
Who is the assignee on this patent?
Procter & Gamble
What technology area does this patent fall under?
Primary CPC classification A61F13/8405. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).